Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b

American Journal of Gastroenterology

Volumn 91, Issue 12, 1996, Pages 2560-2562

  Zein, Nizar N ^a   Poterucha, John J ^a   Gross Jr , John B ^a   Wiesner, Russell H ^a   Therneau, Terry M ^a   Gossard, Andrea A ^a   Wendt, Nadeen K ^a   Mitchell, P Shawn ^a   Germer, Jeff J ^a   Persing, David H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029853873     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Okuda K, Fujimoto I, Hanai A, et al. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
2. Saracci R, Repetto F. Time trends of primary liver cancer: Indication of increased incidence in selected cancer registry population. J Natl Cancer Inst 1980;65:241-7.
3. Kew MC, Houghton M, Choo QL, et al. Hepatitis C antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1991; 335:873-4.
4. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-6.
5. Houghton M, Weiner AJ, Han J, et al. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991;14;381-8.
6. Okamoto H, Kurai K, Okada S, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 1992;188:331-41.
7. Zein NN, Rakela J, Persing DH. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the USA. Mayo Clin Proc 1995;70:449-52.
8. Zein NN, Rakela J, Krawitt EL, et al. Hepatitis C genotypes in the USA: Epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996;125:634-9.
9. Simmonds P, Alberti A, Bonino F, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19: 1321-4.
10. Pozzato G, Moretti M, Franzin F, et al. Severity of liver disease with different hepatitis C viral clones. Lancet 1991;338:509 (letter).
11. Nousbaum JB, Pol S, Nalpas B, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
12. Zein NN, Rakela J, Poterucha JJ, et al. Hepatitis C genotypes in liver transplant recipients: Distribution and one year follow-up. J Liver Transplant Surg 1995;6:354-7.
13. Gordon FD, Zein NN, Poterucha JJ, et al. Hepatitis C genotype 1b in liver transplant recipients is associated with an increased incidence and severity of recurrence. Gastroenterology 1995;108:1074 (abstract).
14. Reid AE, Jeffers LJ, Reddy KR, et al. Hepatitis C genotypes and hepatocellular carcinoma. Hepatology 1994;20;A250 (abstract).
15. De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995;345:413-5.
16. Takahashi M, Yamada G, Miyamoto R, et al. Natural course of chronic hepatitis C infection. Am J Gastroenterol 1993;88:240-3.
17. Yano M, Yatsuhashi H, Inoue O, et al. Epidemiology and long-term prognosis of hepatitis C virus in Japan. Gut 1993;34(suppl):S13-6.
18. Di Bisceglie AM, Goodman ZD, Ishak KJ, et al. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.
19. Hopf U, Moller B, Kuther D, et al. long-term follow-up of posttransfusion and sporadic chronic non-A, non-B hepatitis and frequency of circulating antibodies to hepatitis C virus. J Hepatol 1990;10:69-76.
20. Takada N, Takase S, Takada A, et al. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993;17:277-83.
21. Gonzalez-Peralta R, Lau JYN. Pathogenesis of hepatocellular damage in chronic hepatitis C infection. Semin Gastrointest Dis 1995;6:28-34.
22. Pol S, Thiers V, Nousbaum JB, et al. The changing relative prevalence of hepatitis C virus genotypes: Evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995;108:581-3.